Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCHARPENTIER, S.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGALINSKI, Michel
dc.contributor.authorBOUNES, V.
dc.contributor.authorRICARD-HIBON, A.
dc.contributor.authorEL-KHOURY, C.
dc.contributor.authorELBAZ, M.
dc.contributor.authorAGERON, F. X.
dc.contributor.authorMANZO-SILBERMAN, S.
dc.contributor.authorSOULAT, L.
dc.contributor.authorLAPOSTOLLE, F.
dc.contributor.authorGERARD, A.
dc.contributor.authorBREGEAUD, D.
dc.contributor.authorBONGARD, V.
dc.contributor.authorBONNEFOY-CUDRAZ, E.
dc.date.accessioned2021-01-19T10:26:24Z
dc.date.available2021-01-19T10:26:24Z
dc.date.issued2020
dc.identifier.issn1757-7241en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/25869
dc.description.abstractEnBackground Studies have shown disparate results on the consequences of morphine use in ST-segment elevation myocardial infarction (STEMI). No study has evaluated alternative treatments that could be at least non-inferior to morphine without its potentially damaging consequences for myocardial function and platelet reactivity. The aim of this study was to evaluate whether nitrous oxide/oxygen plus intravenous acetaminophen (NOO-A) is non-inferior to morphine to control chest pain in STEMI patients. Methods This multicenter, open-label, cluster-randomized, controlled, non-inferiority study compared NOO-A with morphine in 684 prehospital patients with ongoing suspected STEMI of < 12 h duration and a pain rating score ≥ 4. The primary endpoint was the proportion of patients achieving pain relief (numeric rating score ≤ 3) after 30 min. Secondary safety endpoints included serious adverse events and death at 30 days. Results The median baseline pain score was 7.0 in both groups. The primary endpoint occurred in 51.7% of the NOO-A group and 73.6% of the morphine group (absolute risk difference − 21.7%; 95% confidence interval − 29.6 to − 13.8). At 30 days, the rate of serious adverse events was 16.0 and 18.8% in the NOO-A and morphine groups respectively (p = NS). The rate of death was 1.8% (NOO-A group) and 3.8% (morphine group) (p = NS). Conclusion Analgesia provided by NOO-A was inferior to morphine at 30 min in patients with acute STEMI in the prehospital setting. Rates of serious adverse events did not differ between groups.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title.enNitrous oxide/oxygen plus acetaminophen versus morphine in ST elevation myocardial infarction: open-label, cluster-randomized, non-inferiority study
dc.title.alternativeScand J Trauma Resusc Emerg Meden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s13049-020-00731-yen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed32398160en_US
bordeaux.journalScand J Trauma Resusc Emerg Meden_US
bordeaux.page36en_US
bordeaux.volume28en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03114785
hal.version1
hal.date.transferred2021-01-19T10:26:29Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Scand%20J%20Trauma%20Resusc%20Emerg%20Med&amp;rft.date=2020&amp;rft.volume=28&amp;rft.issue=1&amp;rft.spage=36&amp;rft.epage=36&amp;rft.eissn=1757-7241&amp;rft.issn=1757-7241&amp;rft.au=CHARPENTIER,%20S.&amp;GALINSKI,%20Michel&amp;BOUNES,%20V.&amp;RICARD-HIBON,%20A.&amp;EL-KHOURY,%20C.&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée